Christopher Weldon, MD, PhD
|Hospital Title||Assistant in Surgery|
|Academic Title||Instructor in Surgery|
300 Longwood Avenue
Boston, MA 02115
Dr. Weldon's research focuses on the development of novel drug-delivery platforms. His work is conducted under the mentoring of Dr. Daniel Kohane, M.D., Ph.D, in the Department of Anesthesia.
About Christopher Weldon
Dr. Weldon was born and raised in California, and then attended the University of Notre Dame, where he received a Bachelor of Arts Degree in English and Pre-Professional Studies. After earning his undergraduate degree, he attended Tulane University Medical Schol, where he graduated in 1995. He then entered the Surgical Residency training program at Tulane Medical Center/Charity Hospital where he completed his General Surgery Residency and Surgical Critical Care Fellowship. While a resident he also received a Doctorate of Philosophy in Pharmacology from the Tulane University Graduate School. After these endeavors, he finished a Pediatric Surgery Fellowship at Boston Children's Hospital.
Yu DC, Linden BC, Anderson ME, Weldon CB. Use of a distal arteriovenous fistula in a complex vascular reconstruction after resection of an osteosarcoma in a high-risk child. J Pediatr Surg. 2009 Feb; 44(2): 459-63.
Yu DC, Javid PJ, Chikwava KR, Kozakewich HP, Debiec-Rychter M, Lillehei CW, Weldon CB. Mesenteric lipoblastoma presenting as a segmental volvulus. J Pediatr Surg. 2009 Feb; 44(2): e25-8.
Gutweiler JR, Labelle J, Suh MY, Misra MV, Ahmed M, Lee EY, Vargas SO, Kim HB, Weldon CB. A familial case of pleuropulmonary blastoma. Eur J Pediatr Surg. 2008 Jun; 18(3): 192-4.
Weldon CB, Shamberger RC. Pediatric pulmonary tumors: primary and metastatic. Semin Pediatr Surg. 2008 Feb; 17(1): 17-29.
Weldon CB, McKee A, Collins-Burow BM, Melnik LI, Scandurro AB, McLachlan JA, Burow ME, Beckman BS. PKC-mediated survival signaling in breast carcinoma cells: a role for MEK1-AP1 signaling. Int J Oncol. 2005 Mar; 26(3): 763-8.
Weldon CB, Elliott S, Zhu Y, Clayton JL, Curiel TJ, Jaffe BM, Burow ME. Regulation of estrogen-mediated cell survival and proliferation by p160 coactivators. Surgery. 2004 Aug; 136(2): 346-54.
Weldon CB, Parker AP, Patten D, Elliott S, Tang Y, Frigo DE, Dugan CM, Coakley EL, Butler NN, Clayton JL, Alam J, Curiel TJ, Beckman BS, Jaffe BM, Burow ME. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. Int J Oncol. 2004 Jun; 24(6): 1473-80.
Weldon CB, Scandurro AB, Rolfe KW, Clayton JL, Elliott S, Butler NN, Melnik LI, Alam J, McLachlan JA, Jaffe BM, Beckman BS, Burow ME. Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray. Surgery. 2002 Aug; 132(2): 293-301.
Weldon CB, Burow ME, Rolfe KW, Clayton JL, Jaffe BM, Beckman BS. NF-kappa B-mediated chemoresistance in breast cancer cells. Surgery. 2001 Aug; 130(2): 143-50.
- All of Dr. Weldon's publications on PubMed